Rahway, NJ, United States of America

Ashok Maliakal

This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok Maliakal. Retrieved from https://idiyas.com/inventor/ashok-maliakal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ashok Maliakal: Innovator in Pharmaceutical Chemistry

Introduction

Ashok Maliakal is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target cyclooxygenase-2 (COX-2) mediated diseases. With a total of 2 patents, his work has implications for the treatment of various medical conditions.

Latest Patents

Maliakal's latest patents include a process for making 2-aryl-3-aryl-5-halo pyridines, which are useful in the treatment of COX-2 mediated diseases. This invention encompasses a process for synthesizing compounds of Formula I, which are critical in addressing inflammation and pain associated with these diseases.

Career Highlights

Ashok Maliakal is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to focus on innovative research and development in the pharmaceutical sector, contributing to advancements in drug formulation and therapeutic applications.

Collaborations

Maliakal has collaborated with esteemed colleagues such as Philip J Pye and Kai Rossen. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations in the field.

Conclusion

In summary, Ashok Maliakal is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in the treatment of COX-2 mediated diseases. His contributions continue to influence the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…